HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Profit from the Pros – Zacks Free Email Newsletter
Our free email newsletter is filled with timely stock picks and market commentary. Sign up for free. Already on board? Check out the archive.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


AZN: Astrazeneca Plc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
ASTRAZENECA PLC (NYSE)
AZN 44.82 -0.37 (-0.82%) Vol.  1,304,437 16.00 CST

Nov 21, 2009 AstraZeneca Seeks FDA Approval
Nov 20, 2009 U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
Nov 20, 2009 AstraZeneca and the Philadelphia Department of Public Health Provide Free Medicines to Pennsylvania's Uninsured
Nov 19, 2009 AstraZeneca reports submission of NDA for ticagrelor
Nov 19, 2009 AstraZeneca Submits US New Drug Application for Ticagrelor (BRILINTA(TM)), an Investigational Antiplatelet Agent
Nov 18, 2009 Results From Two Phase II Trials Add to Understanding of Ticagrelor (BRILINTA(TM)) and How it Works in the Body
Nov 17, 2009 Video: Crestor(R) Reduced Risk of Cardiovascular Events in Women by Nearly Half in New Analysis of Jupiter Study
Nov 17, 2009 Video: CRESTOR(R) Reduced Risk of Cardiovascular Events in Women by Nearly Half in New Analysis of JUPITER Study
Nov 17, 2009 AstraZeneca (AZN) Could Break New Resistance Levels Today
Nov 16, 2009 MedImmune Announces Winners of the 4th Respiratory, Immunology and Autoimmunity Research Abstract Competition
Nov 16, 2009 Zacks Analyst Blog Highlights: GlaxoSmithKline plc, Sanofi-Aventis, Novartis, Baxter International and AstraZeneca
Nov 15, 2009 Video: Ticagrelor (BRILINTA(TM)) Demonstrated Greater Efficacy Over Clopidogrel in the Most Urgent Clinical Setting: Patients with ST-Segment Elevation Myocardial Infarction and Planned Percutaneous Coronary Intervention (PCI)
Nov 12, 2009 TheFortuneFinancial.com Research Partners Tracking LTD, AVT, KFT,HTE, LUK and AZN
Nov 11, 2009 Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps
Nov 11, 2009 Actress Debi Mazar Talks About her Family's Experience with Bipolar Depression
 
ZACKS COMMENTARY FOR AZN
Nov 20, 2009 Zacks Blog: Pozen Initiates New Phase III
Nov 20, 2009 Zacks Blog: AstraZeneca Seeks FDA Approval
Nov 19, 2009 Zacks Equity Research: Report for AZN
Nov 16, 2009 Zacks Blog: Zacks Analyst Blog Highlights: GlaxoSmithKline plc, Sanofi-Aventis, Novartis, Baxter International and AstraZeneca
Nov 16, 2009 Zacks Blog: Zacks #1 Rank Additions for Monday
Nov 13, 2009 Zacks Blog: Glaxo H1N1 Vaccine Approved
Nov 13, 2009 Zacks Blog: AstraZeneca Beats, Raises
Nov 11, 2009 Zacks Blog: Cornerstone Tops Zacks Ests
Nov 11, 2009 Zacks #1 Rank Top Performers: Top Performer for Wed: Santarus (SNTS)
Nov 10, 2009 Zacks Analyst Interviews: Big Pharma & Biotech
Nov 10, 2009 Industry Outlook: Big Pharma & Biotech
Nov 09, 2009 Zacks Blog: Big Pharma and Biotech

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research